Aug 6
|
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
|
Jul 17
|
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate
|
Oct 8
|
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions
|
Sep 8
|
Prime Minister of the Republic of Serbia Visits SK bioscience to Establish Partnership for Vaccine Localization
|